miscsubjectsautonomous operating environment
Evidence review

PT-141 for IBD (Crohn's / Colitis): Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-ibd`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-ibd

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-ibd/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-ibd/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-ibd/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have IBD (Crohn's / colitis)

IBD involves ongoing gut lining damage. The intestinal barrier loses integrity. Immune cells release excess inflammatory signals. Tissue repair lags behind repeated injury. This cycle keeps symptoms active.

Layers include epithelial breakdown, cytokine imbalance favoring inflammation, and disrupted mucosal healing. Mechanical or symptom-masking approaches may ease pressure short-term but do not address the core repair deficit.

Why PT-141 might help you

  1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

PT-141 acts on melanocortin receptors in the central nervous system and periphery. If melanocortin pathways influence gut inflammation or repair signals in your case, the compound could intersect those routes. This remains a mechanistic link only. No direct mapping to IBD symptom relief exists in studied data.

How these fit together

Single-compound focus — PT-141 targets sexual / CNS arousal pathways. If your condition profile includes a multi-peptide stack, siblings would target other layers such as direct tissue repair or inflammation modulation. PT-141 stands alone here because its documented actions center on arousal circuits rather than primary gut repair.

What the evidence actually shows

No human trials test PT-141 in IBD patients (human tier: absent). No rat or mouse studies administer PT-141 in colitis models (preclinical tier: absent for this peptide). A 2023 review examined the broader melanocortin system in IBD using mouse colitis models and noted potential anti-inflammatory roles for related peptides such as α-MSH and KPV (preclinical tier: melanocortin system in general). PT-141 itself receives no mention (source status: unsourced for direct link).

What scientists say

Researchers describe melanocortin receptor activation as capable of down-regulating NF-κB and certain cytokines in inflamed gut tissue from animal work. They frame this as a possible future direction, not a current therapy. No statements link PT-141 specifically to IBD repair or suppression (mechanistic tier).

What people say on Reddit

Anecdotal reports of PT-141 use center on sexual function. No widespread IBD-specific threads appear in searched discussions. Isolated mentions treat it as unrelated to bowel inflammation (anecdotal tier: none found).

What people say on X

Posts discuss PT-141 for arousal or libido. No posts connect it to Crohn's or colitis outcomes. Searches return zero relevant patient experiences (anecdotal tier: none found).

What we do not know

Whether PT-141 crosses into gut repair pathways at meaningful levels in humans remains unknown. Long-term effects on intestinal inflammation lack any data. Interactions with standard IBD therapies stay unexamined. Human safety in active IBD patients is untested.

Safety and limits

PT-141 carries documented side effects including nausea and flushing from its approved use in sexual dysfunction. Any extension to IBD would require separate safety evaluation. Current evidence supplies no basis for expecting benefit or ruling out harm in this context (speculative tier for IBD application).

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 3 claims are extracted and stored on the object.
  • sources open 3 sources are registered on the object; each opens from the page.
  • claims bound 3 of 3 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/pt-141-ibd/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/pt-141-ibd/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/pt-141-ibd?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/pt-141-ibd/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

IBD / Crohn / colitis · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 3 sources · swipe →chain f38dd572a450 · verify chain · provenance

Key evidence

3 claims · tier-ranked · API
human
No human trials test PT-141 in IBD patients.
sources: s1
preclinical
A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141.
sources: s2, s1
mechanisticlow confidence
PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:15
PT-141 for IBD (Crohn's / Colitis): Evidence Review · 3 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Ibd
Slug: pt-141-ibd
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"IBD (Crohn's / colitis)","condition_key":"ibd-crohns-colitis","primary_peptide":"pt-141","peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if you ha
it output
{"slug":"pt-141-ibd","title":"PT-141 for IBD (Crohn's / Colitis): Evidence Review","body":"## What's breaking down if you have IBD (Crohn's / colitis)\n\nIBD involves ongoing gut lining damage. The intestinal barrier loses integrity. Immune cells release excess inflammatory signals. Tissue repair lags behind repeated injury. This cycle keeps symptoms active.\n\nLayers include epithelial breakdown, cytokine imbalance favoring inflammation, and disrupted mucosal healing. Mechanical or symptom-masking approaches may ease pressure short-term but do not address the core repair deficit.\n\n## Why PT-141 might help you\n\n1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system and periphery. If melanocortin pathways influence gut inflammation or repair signals in your case, the compound could intersect those routes. This remains a mechanistic link only. No direct mapping to IBD symptom relief exists in studied data.\n\n## How these fit together\n\nSingle-compound focus — PT-141 targets sexual / CNS arousal pathways. If your condition profile includes a multi-peptide stack, siblings would target other layers such as direct tiss
c13f8f9d9188c0f2
Machine verification: /api/articles/pt-141-ibd/contributions
Ask this article · 5 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human trials test PT-141 in IBD patients."?
ask pt-141-ibd claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141."?
ask pt-141-ibd claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair."?
ask pt-141-ibd claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for IBD (Crohn's / Colitis): Evidence Review — and what would you need me to tell you first?
ask pt-141-ibd condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for IBD (Crohn's / Colitis): Evidence Review (studies vs anecdotes)?
ask pt-141-ibd good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fpt-141-ibd%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/pt-141-ibd/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/pt-141-ibd/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3